Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.47 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | SQOR | Q9Y6N5 | 3/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31171419 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1MAPK1SMN1; SMN2IMPDH2 | |
| SCHEMBL15805524 | 0.84 | NQO1 (0.48) | KDM4EALDH1A1MAPK1SMN1; SMN2IMPDH2 | |
| SCHEMBL5166743 | 0.80 | KDM4E (0.44) | KDM4EALDH1A1MAPK1SMN1; SMN2IMPDH2 | |
| SCHEMBL5166619 | 0.80 | KDM4E (0.44) | KDM4EALDH1A1MAPK1SMN1; SMN2IMPDH2 | |
| SCHEMBL5167234 | 0.79 | ALDH1A1 (0.42) | KDM4EALDH1A1MAPK1SMN1; SMN2IMPDH2 | |
| SCHEMBL28313759 | 0.79 | KDM4E (0.64) | KDM4EALDH1A1MAPK1SMN1; SMN2IMPDH2 | |
| SCHEMBL4657378 | 0.78 | ALDH1A1 (0.41) | KDM4EALDH1A1MAPK1SMN1; SMN2IMPDH2 | |
| SCHEMBL7830291 | 0.78 | POLB (0.59) | KDM4EALDH1A1MAPK1SMN1; SMN2MAPT | |
| SCHEMBL7820838 | 0.78 | RECQL (0.46) | KDM4EALDH1A1MAPK1SMN1; SMN2IMPDH2 | |
| SCHEMBL52405 | 0.77 | ALDH1A1 (1.00) | KDM4EALDH1A1MAPK1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021041734-A1 | ELECTROCHEMICAL CAPTURE OF LEWIS ACID GASES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-03-04 | — | — | WO | disclosed |
| US-7322927-B2 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2008-01-29 | — | — | US | disclosed |
| US-20060228748-A1 | Hybrid phthalocyanine derivatives and their uses | BIOSITE INCORPORATED | 2006-10-12 | — | — | US | disclosed |
| US-7083984-B2 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2006-08-01 | — | — | US | disclosed |
| US-6964844-B1 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2005-11-15 | — | — | US | disclosed |
| US-20020061602-A1 | Hybrid phthalocyanine derivatives and their uses | GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT | 2002-05-23 | — | — | US | disclosed |
| EP-0670041-B1 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS | BIOSITE DIAGNOSTICS INC (US) | 2002-01-30 | — | — | EP | disclosed |
| US-6251687-B1 | PARTICLE CONTAINING ENERGY DONOR AND ENERGY ACCEPTOR | BIOSITE DIAGNOSTICS, INC. | 2001-06-26 | — | — | US | disclosed |
| US-5824799-A | A SILICON FLUORESCENT DYES FOR DETECTING ANALYTE IN IMMUNOASSAYS | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1998-10-20 | — | — | US | disclosed |
| US-5763189-A | Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1998-06-09 | — | — | US | disclosed |
| EP-0820489-A1 | HYBRID PHTHALOCYANINE DERIVATIVES AND THEIR USES | BIOSITE DIAGNOSTICS INC. (US) | 1998-01-28 | — | — | EP | disclosed |
| US-5656752-A | Preparation of naphthalocyanines | BASF AKTIENGESELLSCHAFT (DE) | 1997-08-12 | — | — | US | disclosed |
| EP-0692002-B1 | METHOD OF PREPARING NAPHTHALOCYANINES | BASF AG (DE) | 1996-12-27 | — | — | EP | disclosed |
| WO-1996029367-A1 | HYBRID PHTHALOCYANINE DERIVATIVES AND THEIR USES | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1996-09-26 | — | — | WO | disclosed |
| EP-0692002-A1 | METHOD OF PREPARING NAPHTHALOCYANINES | BASF AG (DE) | 1996-01-17 | — | — | EP | disclosed |
| WO-1994022960-A1 | METHOD OF PREPARING NAPHTHALOCYANINES | BASF AKTIENGESELLSCHAFT (DE) | 1994-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060228748-A1 | Hybrid phthalocyanine derivatives and their uses | UACA, PHAX, PTBP1 | KDM4E 4610/4885ALDH1A1 1368/4885MAPK1 3981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.